Bedinvetmab

Bedinvetmab is a monoclonal antibody primarily used for the management of chronic pain in dogs, particularly pain associated with osteoarthritis. Bedinvetmab helps manage chronic pain by blocking a key mediator of pain. Read more

Bedinvetmab is a monoclonal antibody primarily used for the management of chronic pain in dogs, particularly pain associated with osteoarthritis. Bedinvetmab helps manage chronic pain by blocking a key mediator of pain.

Essential insights

• Targeting Nerve Growth Factor (NGF): Bedinvetmab specifically targets and binds to nerve growth factor (NGF).
• Inhibition of NGF activity: By binding to NGF, Bedinvetmab prevents NGF from interacting with its receptors on pain-sensing nerves.
• Reduction of pain: This inhibition reduces the activation of pain pathways and decreases the sensation of pain in the affected areas.